EACD / IAACD 2025 (Professor Jan Kirschner)

We catch up with Professor Jan Kirschner! Gene therapy for childhood onset disability from neuromuscular disorders: What lessons have you learned from gene therapy in neuromuscular disorders, and how do you see this approach evolving in the future? Another brilliant interview with researchers from EACD / IAACD 2025 at Heidelberg Germany!